|
| 昭衍新药(603127)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2023-04-21 | 18.79 | 0.04% | 53535.04 | 32.82 | 45016.60 | 84.04% | 股权激励限售股份 | | 2022-12-02 | 20.03 | 0.04% | 53516.26 | 51.61 | 45016.60 | 84.04% | 股权激励限售股份 | | 2022-11-23 | 49.94 | 0.09% | 53496.23 | 71.64 | 44996.57 | 84.00% | 股权激励期权行权 | | 2022-11-07 | 5.59 | 0.01% | 53446.28 | 71.64 | 44946.63 | 83.98% | 股权激励一般股份 | | 2022-10-14 | 93.20 | 0.17% | 53440.70 | 71.64 | 44941.04 | 83.98% | 股权激励期权行权 | | 2022-09-14 | 6.17 | 0.01% | 53347.50 | 71.64 | 44847.84 | 83.95% | 股权激励限售股份 | | 2022-06-10 | 2.94 | 0.01% | 38100.95 | 63.27 | 32029.76 | 83.93% | 股权激励期权行权 | | 2021-12-07 | 63.31 | 0.17% | 32026.82 | 26.64 | 32026.82 | 84.01% | 股权激励期权行权 | | 2021-10-27 | 27.11 | 0.07% | 31963.51 | 26.64 | 31990.15 | 84.05% | 股权激励限售流通 | | 2021-04-30 | 17.07 | 0.06% | 22707.08 | 38.39 | 22745.47 | 83.99% | 股权激励限售流通 | | 2020-10-29 | 27.16 | 0.12% | 22619.03 | 55.46 | 22674.49 | 100.00% | 股权激励限售流通 | | 2020-08-25 | 11507.27 | 50.75% | 22591.87 | 82.62 | 22674.49 | 100.00% | 发行前股份限售流通 | | 2020-05-11 | 18.23 | 0.11% | 7897.70 | 8273.99 | 16171.69 | 100.00% | 股权激励限售流通 | | 2019-04-29 | 31.95 | 0.20% | 7845.27 | 8253.97 | 16099.24 | 100.00% | 股权激励限售流通 | | 2018-08-27 | 2710.95 | 23.57% | 5580.95 | 5918.51 | 11499.46 | 100.00% | 发行前股份限售流通 |
|